[unable to retrieve full-text content]

An experimental Alzheimer's vaccine appears to safely clear abnormal tau protein from the brain, but it's not yet clear whether the shot will be able to save brain function. In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack...